ANG LI to Quality-Adjusted Life Years
This is a "connection" page, showing publications ANG LI has written about Quality-Adjusted Life Years.
Connection Strength
0.298
-
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States. Cancer. 2020 04 15; 126(8):1736-1748.
Score: 0.152
-
Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States. Thromb Res. 2019 Aug; 180:37-42.
Score: 0.145